• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine.

作者信息

Stall G M, Harris S, Sokoll L J, Dawson-Hughes B

机构信息

USDA Human Nutrition Research Center on Aging, Tufts University, Boston, Massachusetts.

出版信息

Ann Intern Med. 1990 Aug 15;113(4):265-9. doi: 10.7326/0003-4819-113-4-265.

DOI:10.7326/0003-4819-113-4-265
PMID:2375563
Abstract

OBJECTIVE

To compare the rate of bone mineral loss in thyroxine-treated women with low thyrotropin (thyroid stimulating hormone, TSH) levels with that in women without known thyroid disease.

DESIGN

Cases selected from a prospective calcium trial.

SETTING

Subjects were recruited from the Boston area.

MEASUREMENTS AND MAIN RESULTS

Of 361 women enrolled in a 2-year calcium supplement trial, 18 received thyroxine for hypothyroidism. Of these, 10 were considered overtreated, because they had low TSH levels. Rates of loss of bone mineral density from the radius, spine, and hip during 1.9 +/- 0.6 years were measured by single- and dual-photon absorptiometry. When compared with women with no known thyroid disease (236 controls for the spine, 246 for the radius, and 237 for the femoral neck), women with low TSH levels had greater annualized, adjusted mean rates of bone loss from the spine (-2.89% +/- 0.65% compared with -1.13% +/- 0.13%, P = 0.009) and similar but not significant trends at the radius (-1.18% +/- 0.75% compared with -0.13% +/- 0.17%) and femoral neck (-1.39% +/- 0.80% compared with -0.28% +/- 0.19%). These means were adjusted for variables that affected the rate of loss in the control group (baseline bone mineral density and body mass index, calcium intake, and years since menopause). There were no statistical differences between the low TSH and control groups for any laboratory variables measured, including serum calcium, phosphorus, parathyroid hormone or alkaline phosphatase, plasma 25-hydroxyvitamin D or 1,25-dihydroxyvitamin D, or 24-hour urine calcium-to-creatinine ratio.

CONCLUSIONS

Thyroxine-treated women with low TSH levels lose bone mineral from the spine more rapidly than do women without known thyroid disease. These patients are therefore at increased risk for osteoporosis. The absence of detectable biochemical changes in women with low TSH levels may result from their relatively modest degree of overtreatment.

摘要

相似文献

1
Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine.
Ann Intern Med. 1990 Aug 15;113(4):265-9. doi: 10.7326/0003-4819-113-4-265.
2
Longitudinal changes of bone mineral density and bone turnover in postmenopausal women on thyroxine.甲状腺素治疗的绝经后女性骨矿物质密度和骨转换的纵向变化
Clin Endocrinol (Oxf). 1997 Mar;46(3):301-7. doi: 10.1046/j.1365-2265.1997.1280950.x.
3
Bone mineral density in postmenopausal women treated with L-thyroxine.接受左甲状腺素治疗的绝经后女性的骨矿物质密度
Am J Med. 1991 Mar;90(3):360-6. doi: 10.1016/0002-9343(91)90577-k.
4
Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.促甲状腺激素与甲状腺激素对绝经前女性骨密度和骨转换的调节作用
Endocr Regul. 2010 Apr;44(2):57-63. doi: 10.4149/endo_2010_02_57.
5
Effects of thyroxine therapy on bone metabolism in postmenopausal women with hypothyroidism.甲状腺素治疗对绝经后甲状腺功能减退女性骨代谢的影响。
Acta Obstet Gynecol Scand. 1996 Oct;75(9):843-8. doi: 10.3109/00016349609054714.
6
A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.小剂量抑制性左甲状腺素对患有非毒性甲状腺肿的绝经前和绝经后女性的骨转换及骨密度无影响。
Horm Metab Res. 1995 Nov;27(11):503-7. doi: 10.1055/s-2007-980012.
7
Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.长期接受甲状腺激素抑制治疗的绝经前女性的骨质流失。
Medscape Womens Health. 2001 Oct;6(5):3.
8
Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.接受超生理剂量甲状腺素治疗的甲状腺癌患者的骨密度变化和骨转换
Eur J Med Res. 2005 Nov 16;10(11):480-8.
9
Suppressive doses of thyroxine do not accelerate age-related bone loss in late postmenopausal women.甲状腺素的抑制剂量不会加速绝经后期女性与年龄相关的骨质流失。
Thyroid. 1995 Feb;5(1):13-7. doi: 10.1089/thy.1995.5.13.
10
Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.接受分化型甲状腺癌甲状腺素抑制治疗的女性的骨矿物质密度
J Formos Med Assoc. 2004 Jun;103(6):442-7.

引用本文的文献

1
Investigating the causal relationship between thyroid dysfunction diseases and osteoporosis: a two-sample Mendelian randomization analysis.探讨甲状腺功能障碍性疾病与骨质疏松症之间的因果关系:两样本孟德尔随机分析。
Sci Rep. 2024 Jun 4;14(1):12784. doi: 10.1038/s41598-024-62854-x.
2
Association between serum TSH concentration and bone mineral density: an umbrella review.血清促甲状腺激素浓度与骨密度之间的关联:一项伞状综述。
Hormones (Athens). 2024 Sep;23(3):547-565. doi: 10.1007/s42000-024-00555-w. Epub 2024 Apr 6.
3
Towards De-Implementation of low-value thyroid care in older adults.
向老年人群中低价值甲状腺护理的去执行化迈进。
Curr Opin Endocrinol Diabetes Obes. 2022 Oct 1;29(5):483-491. doi: 10.1097/MED.0000000000000758. Epub 2022 Jul 22.
4
Understanding Worry About Risks Associated With Thyroid Hormone Therapy: A National Survey of Endocrinologists, Family Physicians, and Geriatricians.了解甲状腺激素治疗相关风险的担忧:内分泌学家、家庭医生和老年病学家的全国性调查。
Endocr Pract. 2022 Jan;28(1):25-29. doi: 10.1016/j.eprac.2021.08.007. Epub 2021 Aug 24.
5
Levothyroxine Therapy in Elderly Patients With Hypothyroidism.老年甲状腺功能减退症患者的左甲状腺素治疗。
Front Endocrinol (Lausanne). 2021 Mar 12;12:641560. doi: 10.3389/fendo.2021.641560. eCollection 2021.
6
Thyroid Hormone Diseases and Osteoporosis.甲状腺激素疾病与骨质疏松症
J Clin Med. 2020 Apr 6;9(4):1034. doi: 10.3390/jcm9041034.
7
Influence of Thyroid-stimulating Hormone Suppression Therapy on Bone Mineral Density in Patients with Differentiated Thyroid Cancer: A Meta-analysis.促甲状腺激素抑制疗法对分化型甲状腺癌患者骨密度的影响:一项Meta分析。
J Bone Metab. 2019 Feb;26(1):51-60. doi: 10.11005/jbm.2019.26.1.51. Epub 2019 Feb 28.
8
Stable Isotope Pharmacokinetic Studies Provide Insight into Effects of Age, Sex, and Weight on Levothyroxine Metabolism.稳定同位素药代动力学研究为年龄、性别和体重对左甲状腺素代谢的影响提供了深入了解。
Thyroid. 2018 Jan;28(1):41-49. doi: 10.1089/thy.2017.0380. Epub 2018 Jan 2.
9
Primary hypothyroidism in the community: Lower daily dosages of levothyroxine replacement therapy for Asian patients.社区中的原发性甲状腺功能减退症:亚洲患者左甲状腺素替代治疗的每日剂量较低。
Medicine (Baltimore). 2017 Feb;96(7):e6145. doi: 10.1097/MD.0000000000006145.
10
Congenital Hypothyroidism and Bone Remodeling Cycle.先天性甲状腺功能减退症与骨重塑周期
J Clin Res Pediatr Endocrinol. 2017 Jun 1;9(2):106-110. doi: 10.4274/jcrpe.3532. Epub 2016 Nov 9.